NR341 PHARM TEST QUESTIONS WITH
CORRECT ANSWERS 2025
AlbuterolHContraindications/PrecautionsH-HCORRECTHANSWERH-
cardiacHdisease,HHPT,Hhyperthyroidism,Hdiabetes,Hglaucoma,HseizureHdisorders
AlbuterolHIndiciationsH-HCORRECTHANSWERH-
adrenergicHusedHasHaHbronchodilatorHtoHcontrolH&HpreventHreversibleHairwayHobstructionHcausedH
byHasthmaHorHCOPD
AlbuterolHSideHEffectsH-HCORRECTHANSWERH-
nervousness,Hrestlessness,Htremor,HHA,HinsomniaH(occursHmoreHinHchildren),HhyperactivityHinHchil
dren,HparadoxicalHbronchospasmH(dueHtoHexcessiveHuseHofHinhales),HchestHpain,Hpalpitations,Hangi
na,Harrhythmias,HHPT,HN/V,Hhyperglycemia,Hhypokalemia,Htremor
AlbuterolHInteractionsH-HCORRECTHANSWERH-
MAOI'sHleadHtoHhypertensiveHcrisis;HbetaHblockersHnegateHtherapeuticHeffect;HdecreaseHdigoxinHle
vels;HriskHofHhypokalemiaHincreasesHw/useHofHK+HlosingHdiureticsH(hypokalemiaHincreasesHtheHriskH
ofHdigoxinHtoxicity);HuseHw/caffeine-
containingHherbsH(colaHnut,Hguarana,Htea,Hcoffee)HincreasesHstimulantHeffect
AlbuterolHNursingHImplicationsH-HCORRECTHANSWERH-
monitor/reportHtachycardia,HheartHpalpitations,H&HchestHpain;Hmonitor/reportHtremors
AlbuterolHPatientHTeachingH-HCORRECTHANSWERH-
reportHchestHpainH&HheartHpalpitations;HreportHincreaseHinHpulseHrate;HavoidHcaffeine;HnotifyHPCPHi
fHtremorsHinterfereHwithHADLs
T-PAHIndicationsH-HCORRECTHANSWERH-
tissueHplasminogenHactivatorH&HrecombinantHapprovedHbyHtheHU.SHFDAHforHIVHthrombolysisHinHac
,uteHischemicHstrokeHw/inH3HhoursHofHonsetHofHstrokeHsymptoms;HonlyHapprovedHforHPT'sH18yoH&Ho
lder
t-PAH-HCORRECTHANSWERH-Alteplase
AlbuterolH-HCORRECTHANSWERH-Ventolin
T-PAHPrecautions/ContraindicationsH-HCORRECTHANSWERH-
unclearHtime/unwitnessedHsymptomHonset/lastHknownHbaselineHstateHgreaterHthanH3-
4.5Hhrs;HcurrentHorHHXHofHICHhemorrhage;HCTHshowingHhypoattenuationHorHhypoperfusionHrepres
entingHirreversibleHinjury;HrecentH(w/inH3Hmonths)HischemicHstroke,HsevereHheadHtrauma,HorHintra
cranial/intraspinalHsurgery;HSubarachnoidHhemorrhage;HGIHmalignancyHorHGIHbleedHwithinH21Hday
sHofHstrokeHevent;HICHconditionsHthatHmayHincreaseHriskHofHbleedingH(suchHasHintracranialHneoplas
m,HarteriovenousHmalformation,HorHaneurysm);HCoagulopathy;HLowHmolecularHweightHheparinH(L
MWH)HtreatmentHdosesHwithinHtheHpreviousH24Hhrs;HCurrentHuseHofHanticoagulantHwithHINRH>H1.7
HorHPTH>H15Hseconds;HCurrentHuseHofHdirectHthrombinHinhibitorsHorHdirectHfactorHXaHinhibitorsHw/el
evatedHlaboratoryHtests;HConcurrentHuseHofHglycoproteinHIIb/IIIaHreceptorHinhibitors;HInfectiveHen
docarditis;HAorticHarchHdissection;HIntra-axialHintracranialHneoplasmH-
HlesionsHlocatedHwithinHtheHbrainHtissue
T-PAHAdverseHEffectsH-HCORRECTHANSWERH-
BleedingH(mostHcommon);HOrolingualHangioedema;HArrhythmias;HHypotension;HEdema;HCholeste
rolHembolization;HVenousHthrombosis;HRe-
embolizationHofHdeepHvenousHthrombiH(DVT)HinHpatientsHwithHpulmonaryHembolims;HNausea;HVo
miting;HHypersensitivityHreactions
T-PAHInteractionsH-HCORRECTHANSWERH-
Warfarin;HaspirinH(ASA);HNSAID'sH(Ibuprofen,HNaproxen,HNabumetone,HandHplateletHinhibitorsHsuc
hHas-
Plavix,HEffeint,HKengreal,HandHBrilinta);HBCHAlteplaseHbreaksHdownHclotsH&HinterferesHw/theHbody's
HabilityHtoHstopHbleeding,HanyHdrugsHthatHalsoHinterfereHw/theHbody'sHabilityHtoHformHbloodHclotsHc
anHincreaseHtheHriskHofHbleedingHinHpatients
,T-PAHPatientHTeachingH-HCORRECTHANSWERH-
mustHbeHusedHw/inH8HhrsHofHbeingHopened;HcanHalterHtheHtestHresultsHofHcoagulationH&Hfibrinolytic
HactivityHtests;HhaveHpatientHimmediatelyHreportHtoHtheHPCPHanyHsignsHofHbleedingH(vomitingHbloo
dHorHvomitHthatHlooksHlikeHcoffeeHgrounds;HcoughingHupHblood;Hhematuria;Hblack,Hred,HorHtarryHsto
ols;HbleedingHfromHtheHgums;HabnormalHvaginalHbleedings;HbruisesHwithoutHaHreasonHorHthatHgetH
better);HimmediatelyHreportHtoHtheHPCPHanyHsignsHofHDVTH(edema,Hwarmth,Hnumbness,HchangeHin
Hcolor,HorHpainHinHtheHextremities);HreportHtoHPCPHanyHsevereHcerebrovascularHdiseaseH(changeHinH
strengthHonH1HsideHisHgreaterHthanHtheHother,HdifficultyHspeakingHorHthinking,HchangeHinHbalance,H
orHvisualHchanges)
AmiodaroneH-HCORRECTHANSWERH-Cordarone
AmiodaroneHIndicationsH-HCORRECTHANSWERH-
classHIIIHpotassiumHchannelHblockerHthatHmanagesHlife-threateningHventricular-
tachycardiaHorHfibrillationHthat'sHresistantHtoHotherHdrugs;HmayHtreatHsomeHatrialHdysrhythmias,Hs
uchHasHatrialHfibrillation
AmiodaroneHContraindications/PrecautionsH-HCORRECTHANSWERH-
cardiogenicHshock;HsickHsinusHsyndrome,H2nd-HorH3rd-
degreeHAVHblock,HbradycardiaHleadingHtoHsyncopeHwithoutHaHfunctioningHpacemaker;HanyHknownH
hypersensitivityHtoHtheHdrugHorHtoHanyHofHitsHcomponents,HincludingHiodine;HpulmonaryHtoxicity;Hh
epaticHinjury;HworsenedHarrhythmia;HvisualHimpairmentHorHlossHofHvision;HthyroidHabnormalities;H
bradycardia;HimplantableHcardiacHdevices;HfetalHtoxicity;HperipheralHneuropathy;Hphotosensitivity
H&HskinHdiscoloration;Hsurgery
AmiodaroneHAdverseHEffectsH-HCORRECTHANSWERH-
N/V;Hconstipation;HpulmonaryHtoxicityHw/HpneumonitisH(causingHfever,Hcough,HSOB),HoccursHmostH
frequentlyHw/Hlong-termHand/orHhigh-
doseHuseHandHmayHleadHtoHpulmonaryHfibrosis);HvisualHeffects-
opticHneuropathyHw/possibleHblindnessH&HcornealHmicrodeposits,HwhichHmayHcauseHsevereHsensit
ivityHtoHlight,HblurredHvision;HcardiaHeffects-
bradycardiaH&HhypotensionH(commonHw/HIVHdose);HheartHfailureHmayHbeHworsenedHbyHamiodaro
neHtherapy;Hblue-greyHdiscolorationHofHtheHskin;HCNSHeffects-dizziness,Htremor,Hhallucinations
, AmiodaroneHInteractionsH-HCORRECTHANSWERH-
QTHprolongingHdrugsH(classHIHandHIIIHantiarrhythmics,Hlithium,HtricyclicHantidepressants,HazoleHanti
fungals,Hetc.)-
HincreaseHriskHofHTorsadeHdeHPointes;HNeg.HchronotropesH(digoxin,HbetaHblockers,Hverapamil,Hdiltia
zem,Hclonidine,Hivabradine)-
HcanHresultHinHbradycardia,HsinusHarrest,HandHAVHblock;HSt.HJohn'sHWortH&HCholestyramineHcanHred
uceHtheHlevelsHofHamiodarone;HwarfarinHcanHresultHinHseriousHorHfatalHbleeding;HfentanylHcanHcaus
eHhypotension,Hbradycardia,H&HdecreasedHcardiacHoutput
AmiodaroneHNursingHImplicationsH-HCORRECTHANSWERH-
reduceHdoseHforHsevereHGIHsymptoms;HtestHbaselineHchestHx-
rayH&HpulmonaryHfunctionHbeforeHstartingHtherapyHBCHtheHdrugHcanHcauseHpulmonaryHtoxicityHw/H
pneumonitisH(causingHfever,Hcough,HSOB);HmonitorHpulmonaryHfunctionHtestingHresultsHperiodicall
y;HauscultateHbreathHsoundsH&HreportHchangesHorHadventitiousHsounds;HmonitorHforHchangesHinHvi
sion,HlightHsensitivity;HmonitorHpulseH&HBP,H&HreportHVSHbelowHtheHprescribedHparameters;Hmonit
orHcardiacHrhythmHconstantlyHduringHinfusion;HmonitorHforHweightHchangesH&HedemaHforHbothHIVH
&HoralHtherapy;HmonitorHforHblue-greyHdiscolorationHofHskin;HreportHCNSHeffects
AmiodaroneHPatientHTeachingH-HCORRECTHANSWERH-
takeHw/foodHorHmilkHifHN/VHorHconstipationHoccurH(butHbeHsureHtoHtakeHatHconsistentHtimesHduring
HtheHday);HcomplyHw/chestHx-
rayH&HpulmHfunctionHtesting;HreportHfever,HdryHcough,HSOB,HorHotherHrespHsymptoms;HreportHsensi
tivityHtoHlightH&HchangesHinHvision;HobtainHregularHophthalmicHcheckups;HwearHsunglasses;HreportH
dizziness,Hsyncope;HforHoralHtherapy,HmonitorHpulseHrateH&HreportHratesHslowerHthanH60BPM;Hrep
ortHweightHgainH&Hedema;HbeHawareHthatHskinHdiscolorationHmayHoccur;HreportHtremor,Hdizziness,H
hallucinations;HavoidHhazardousHactivityHsuchHasHdrivingHifHdizzinessHoccurs;HdueHtoHlongHhalf-
lifeHofHthisHdrug,HavoidHpregnancyH&HbreastfeedingHduringHtherapyH&HforHseveralHmonthsHafterHth
erapyHisHdiscontinued
AmlodipineH-HCORRECTHANSWERH-Norvasc
AmlodipineHIndicationsH-HCORRECTHANSWERH-
calciumHchannelHblockerHusedHtoHtreatHhypertensionHandHangina
CORRECT ANSWERS 2025
AlbuterolHContraindications/PrecautionsH-HCORRECTHANSWERH-
cardiacHdisease,HHPT,Hhyperthyroidism,Hdiabetes,Hglaucoma,HseizureHdisorders
AlbuterolHIndiciationsH-HCORRECTHANSWERH-
adrenergicHusedHasHaHbronchodilatorHtoHcontrolH&HpreventHreversibleHairwayHobstructionHcausedH
byHasthmaHorHCOPD
AlbuterolHSideHEffectsH-HCORRECTHANSWERH-
nervousness,Hrestlessness,Htremor,HHA,HinsomniaH(occursHmoreHinHchildren),HhyperactivityHinHchil
dren,HparadoxicalHbronchospasmH(dueHtoHexcessiveHuseHofHinhales),HchestHpain,Hpalpitations,Hangi
na,Harrhythmias,HHPT,HN/V,Hhyperglycemia,Hhypokalemia,Htremor
AlbuterolHInteractionsH-HCORRECTHANSWERH-
MAOI'sHleadHtoHhypertensiveHcrisis;HbetaHblockersHnegateHtherapeuticHeffect;HdecreaseHdigoxinHle
vels;HriskHofHhypokalemiaHincreasesHw/useHofHK+HlosingHdiureticsH(hypokalemiaHincreasesHtheHriskH
ofHdigoxinHtoxicity);HuseHw/caffeine-
containingHherbsH(colaHnut,Hguarana,Htea,Hcoffee)HincreasesHstimulantHeffect
AlbuterolHNursingHImplicationsH-HCORRECTHANSWERH-
monitor/reportHtachycardia,HheartHpalpitations,H&HchestHpain;Hmonitor/reportHtremors
AlbuterolHPatientHTeachingH-HCORRECTHANSWERH-
reportHchestHpainH&HheartHpalpitations;HreportHincreaseHinHpulseHrate;HavoidHcaffeine;HnotifyHPCPHi
fHtremorsHinterfereHwithHADLs
T-PAHIndicationsH-HCORRECTHANSWERH-
tissueHplasminogenHactivatorH&HrecombinantHapprovedHbyHtheHU.SHFDAHforHIVHthrombolysisHinHac
,uteHischemicHstrokeHw/inH3HhoursHofHonsetHofHstrokeHsymptoms;HonlyHapprovedHforHPT'sH18yoH&Ho
lder
t-PAH-HCORRECTHANSWERH-Alteplase
AlbuterolH-HCORRECTHANSWERH-Ventolin
T-PAHPrecautions/ContraindicationsH-HCORRECTHANSWERH-
unclearHtime/unwitnessedHsymptomHonset/lastHknownHbaselineHstateHgreaterHthanH3-
4.5Hhrs;HcurrentHorHHXHofHICHhemorrhage;HCTHshowingHhypoattenuationHorHhypoperfusionHrepres
entingHirreversibleHinjury;HrecentH(w/inH3Hmonths)HischemicHstroke,HsevereHheadHtrauma,HorHintra
cranial/intraspinalHsurgery;HSubarachnoidHhemorrhage;HGIHmalignancyHorHGIHbleedHwithinH21Hday
sHofHstrokeHevent;HICHconditionsHthatHmayHincreaseHriskHofHbleedingH(suchHasHintracranialHneoplas
m,HarteriovenousHmalformation,HorHaneurysm);HCoagulopathy;HLowHmolecularHweightHheparinH(L
MWH)HtreatmentHdosesHwithinHtheHpreviousH24Hhrs;HCurrentHuseHofHanticoagulantHwithHINRH>H1.7
HorHPTH>H15Hseconds;HCurrentHuseHofHdirectHthrombinHinhibitorsHorHdirectHfactorHXaHinhibitorsHw/el
evatedHlaboratoryHtests;HConcurrentHuseHofHglycoproteinHIIb/IIIaHreceptorHinhibitors;HInfectiveHen
docarditis;HAorticHarchHdissection;HIntra-axialHintracranialHneoplasmH-
HlesionsHlocatedHwithinHtheHbrainHtissue
T-PAHAdverseHEffectsH-HCORRECTHANSWERH-
BleedingH(mostHcommon);HOrolingualHangioedema;HArrhythmias;HHypotension;HEdema;HCholeste
rolHembolization;HVenousHthrombosis;HRe-
embolizationHofHdeepHvenousHthrombiH(DVT)HinHpatientsHwithHpulmonaryHembolims;HNausea;HVo
miting;HHypersensitivityHreactions
T-PAHInteractionsH-HCORRECTHANSWERH-
Warfarin;HaspirinH(ASA);HNSAID'sH(Ibuprofen,HNaproxen,HNabumetone,HandHplateletHinhibitorsHsuc
hHas-
Plavix,HEffeint,HKengreal,HandHBrilinta);HBCHAlteplaseHbreaksHdownHclotsH&HinterferesHw/theHbody's
HabilityHtoHstopHbleeding,HanyHdrugsHthatHalsoHinterfereHw/theHbody'sHabilityHtoHformHbloodHclotsHc
anHincreaseHtheHriskHofHbleedingHinHpatients
,T-PAHPatientHTeachingH-HCORRECTHANSWERH-
mustHbeHusedHw/inH8HhrsHofHbeingHopened;HcanHalterHtheHtestHresultsHofHcoagulationH&Hfibrinolytic
HactivityHtests;HhaveHpatientHimmediatelyHreportHtoHtheHPCPHanyHsignsHofHbleedingH(vomitingHbloo
dHorHvomitHthatHlooksHlikeHcoffeeHgrounds;HcoughingHupHblood;Hhematuria;Hblack,Hred,HorHtarryHsto
ols;HbleedingHfromHtheHgums;HabnormalHvaginalHbleedings;HbruisesHwithoutHaHreasonHorHthatHgetH
better);HimmediatelyHreportHtoHtheHPCPHanyHsignsHofHDVTH(edema,Hwarmth,Hnumbness,HchangeHin
Hcolor,HorHpainHinHtheHextremities);HreportHtoHPCPHanyHsevereHcerebrovascularHdiseaseH(changeHinH
strengthHonH1HsideHisHgreaterHthanHtheHother,HdifficultyHspeakingHorHthinking,HchangeHinHbalance,H
orHvisualHchanges)
AmiodaroneH-HCORRECTHANSWERH-Cordarone
AmiodaroneHIndicationsH-HCORRECTHANSWERH-
classHIIIHpotassiumHchannelHblockerHthatHmanagesHlife-threateningHventricular-
tachycardiaHorHfibrillationHthat'sHresistantHtoHotherHdrugs;HmayHtreatHsomeHatrialHdysrhythmias,Hs
uchHasHatrialHfibrillation
AmiodaroneHContraindications/PrecautionsH-HCORRECTHANSWERH-
cardiogenicHshock;HsickHsinusHsyndrome,H2nd-HorH3rd-
degreeHAVHblock,HbradycardiaHleadingHtoHsyncopeHwithoutHaHfunctioningHpacemaker;HanyHknownH
hypersensitivityHtoHtheHdrugHorHtoHanyHofHitsHcomponents,HincludingHiodine;HpulmonaryHtoxicity;Hh
epaticHinjury;HworsenedHarrhythmia;HvisualHimpairmentHorHlossHofHvision;HthyroidHabnormalities;H
bradycardia;HimplantableHcardiacHdevices;HfetalHtoxicity;HperipheralHneuropathy;Hphotosensitivity
H&HskinHdiscoloration;Hsurgery
AmiodaroneHAdverseHEffectsH-HCORRECTHANSWERH-
N/V;Hconstipation;HpulmonaryHtoxicityHw/HpneumonitisH(causingHfever,Hcough,HSOB),HoccursHmostH
frequentlyHw/Hlong-termHand/orHhigh-
doseHuseHandHmayHleadHtoHpulmonaryHfibrosis);HvisualHeffects-
opticHneuropathyHw/possibleHblindnessH&HcornealHmicrodeposits,HwhichHmayHcauseHsevereHsensit
ivityHtoHlight,HblurredHvision;HcardiaHeffects-
bradycardiaH&HhypotensionH(commonHw/HIVHdose);HheartHfailureHmayHbeHworsenedHbyHamiodaro
neHtherapy;Hblue-greyHdiscolorationHofHtheHskin;HCNSHeffects-dizziness,Htremor,Hhallucinations
, AmiodaroneHInteractionsH-HCORRECTHANSWERH-
QTHprolongingHdrugsH(classHIHandHIIIHantiarrhythmics,Hlithium,HtricyclicHantidepressants,HazoleHanti
fungals,Hetc.)-
HincreaseHriskHofHTorsadeHdeHPointes;HNeg.HchronotropesH(digoxin,HbetaHblockers,Hverapamil,Hdiltia
zem,Hclonidine,Hivabradine)-
HcanHresultHinHbradycardia,HsinusHarrest,HandHAVHblock;HSt.HJohn'sHWortH&HCholestyramineHcanHred
uceHtheHlevelsHofHamiodarone;HwarfarinHcanHresultHinHseriousHorHfatalHbleeding;HfentanylHcanHcaus
eHhypotension,Hbradycardia,H&HdecreasedHcardiacHoutput
AmiodaroneHNursingHImplicationsH-HCORRECTHANSWERH-
reduceHdoseHforHsevereHGIHsymptoms;HtestHbaselineHchestHx-
rayH&HpulmonaryHfunctionHbeforeHstartingHtherapyHBCHtheHdrugHcanHcauseHpulmonaryHtoxicityHw/H
pneumonitisH(causingHfever,Hcough,HSOB);HmonitorHpulmonaryHfunctionHtestingHresultsHperiodicall
y;HauscultateHbreathHsoundsH&HreportHchangesHorHadventitiousHsounds;HmonitorHforHchangesHinHvi
sion,HlightHsensitivity;HmonitorHpulseH&HBP,H&HreportHVSHbelowHtheHprescribedHparameters;Hmonit
orHcardiacHrhythmHconstantlyHduringHinfusion;HmonitorHforHweightHchangesH&HedemaHforHbothHIVH
&HoralHtherapy;HmonitorHforHblue-greyHdiscolorationHofHskin;HreportHCNSHeffects
AmiodaroneHPatientHTeachingH-HCORRECTHANSWERH-
takeHw/foodHorHmilkHifHN/VHorHconstipationHoccurH(butHbeHsureHtoHtakeHatHconsistentHtimesHduring
HtheHday);HcomplyHw/chestHx-
rayH&HpulmHfunctionHtesting;HreportHfever,HdryHcough,HSOB,HorHotherHrespHsymptoms;HreportHsensi
tivityHtoHlightH&HchangesHinHvision;HobtainHregularHophthalmicHcheckups;HwearHsunglasses;HreportH
dizziness,Hsyncope;HforHoralHtherapy,HmonitorHpulseHrateH&HreportHratesHslowerHthanH60BPM;Hrep
ortHweightHgainH&Hedema;HbeHawareHthatHskinHdiscolorationHmayHoccur;HreportHtremor,Hdizziness,H
hallucinations;HavoidHhazardousHactivityHsuchHasHdrivingHifHdizzinessHoccurs;HdueHtoHlongHhalf-
lifeHofHthisHdrug,HavoidHpregnancyH&HbreastfeedingHduringHtherapyH&HforHseveralHmonthsHafterHth
erapyHisHdiscontinued
AmlodipineH-HCORRECTHANSWERH-Norvasc
AmlodipineHIndicationsH-HCORRECTHANSWERH-
calciumHchannelHblockerHusedHtoHtreatHhypertensionHandHangina
